150 related articles for article (PubMed ID: 36796670)
1. PLA2G2A
Ge W; Yue M; Lin R; Zhou T; Xu H; Wang Y; Mao T; Li S; Wu X; Zhang X; Wang Y; Ma J; Wang Y; Xue S; Shentu D; Cui J; Wang L
Cancer Lett; 2023 Apr; 558():216095. PubMed ID: 36796670
[TBL] [Abstract][Full Text] [Related]
2. Intraepithelial Attack Rather than Intratumorally Infiltration of CD8+T Lymphocytes is a Favorable Prognostic Indicator in Pancreatic Ductal Adenocarcinoma.
Zhang J; Wang YF; Wu B; Zhong ZX; Wang KX; Yang LQ; Wang YQ; Li YQ; Gao J; Li ZS
Curr Mol Med; 2017; 17(10):689-698. PubMed ID: 29521231
[TBL] [Abstract][Full Text] [Related]
3. C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pancreatic cancer.
Sasaki K; Takano S; Tomizawa S; Miyahara Y; Furukawa K; Takayashiki T; Kuboki S; Takada M; Ohtsuka M
J Exp Clin Cancer Res; 2021 Jun; 40(1):212. PubMed ID: 34167573
[TBL] [Abstract][Full Text] [Related]
4. Local and systemic immune profiles of human pancreatic ductal adenocarcinoma revealed by single-cell mass cytometry.
Brouwer TP; de Vries NL; Abdelaal T; Krog RT; Li Z; Ruano D; Fariña A; Lelieveldt BPF; Morreau H; Bonsing BA; Vahrmeijer AL; Koning F; de Miranda NFCC
J Immunother Cancer; 2022 Jul; 10(7):. PubMed ID: 35793870
[TBL] [Abstract][Full Text] [Related]
5. IL-17A-producing CD8
Picard FSR; Lutz V; Brichkina A; Neuhaus F; Ruckenbrod T; Hupfer A; Raifer H; Klein M; Bopp T; Pfefferle PI; Savai R; Prinz I; Waisman A; Moos S; Chang HD; Heinrich S; Bartsch DK; Buchholz M; Singh S; Tu M; Klein L; Bauer C; Liefke R; Burchert A; Chung HR; Mayer P; Gress TM; Lauth M; Gaida M; Huber M
Gut; 2023 Aug; 72(8):1510-1522. PubMed ID: 36759154
[TBL] [Abstract][Full Text] [Related]
6. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma.
Ene-Obong A; Clear AJ; Watt J; Wang J; Fatah R; Riches JC; Marshall JF; Chin-Aleong J; Chelala C; Gribben JG; Ramsay AG; Kocher HM
Gastroenterology; 2013 Nov; 145(5):1121-32. PubMed ID: 23891972
[TBL] [Abstract][Full Text] [Related]
7. DPP inhibition alters the CXCR3 axis and enhances NK and CD8+ T cell infiltration to improve anti-PD1 efficacy in murine models of pancreatic ductal adenocarcinoma.
Fitzgerald AA; Wang S; Agarwal V; Marcisak EF; Zuo A; Jablonski SA; Loth M; Fertig EJ; MacDougall J; Zhukovsky E; Trivedi S; Bhatia D; O'Neill V; Weiner LM
J Immunother Cancer; 2021 Nov; 9(11):. PubMed ID: 34737215
[TBL] [Abstract][Full Text] [Related]
8. PLA2G2A Phospholipase Promotes Fatty Acid Synthesis and Energy Metabolism in Pancreatic Cancer Cells with
Zhang M; Xiang R; Glorieux C; Huang P
Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233022
[TBL] [Abstract][Full Text] [Related]
9. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response.
Wang Y; Liang Y; Xu H; Zhang X; Mao T; Cui J; Yao J; Wang Y; Jiao F; Xiao X; Hu J; Xia Q; Zhang X; Wang X; Sun Y; Fu D; Shen L; Xu X; Xue J; Wang L
Cell Discov; 2021 May; 7(1):36. PubMed ID: 34035226
[TBL] [Abstract][Full Text] [Related]
10. The Tango between Cancer-Associated Fibroblasts (CAFs) and Immune Cells in Affecting Immunotherapy Efficacy in Pancreatic Cancer.
Stouten I; van Montfoort N; Hawinkels LJAC
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240052
[TBL] [Abstract][Full Text] [Related]
11. Prosaposin, tumor-secreted protein, promotes pancreatic cancer progression by decreasing tumor-infiltrating lymphocytes.
Miyahara Y; Takano S; Sogawa K; Tomizawa S; Furukawa K; Takayashiki T; Kuboki S; Ohtsuka M
Cancer Sci; 2022 Aug; 113(8):2548-2559. PubMed ID: 35633503
[TBL] [Abstract][Full Text] [Related]
12. Tumor-infiltrating OX40
Zhang Q; Rui W; Jiang Y; Yuan F; Chen Y; Guo X; Zhou Y; Wu Z; Wang C; Ding X
Clin Transl Oncol; 2022 Oct; 24(10):2029-2038. PubMed ID: 35731350
[TBL] [Abstract][Full Text] [Related]
13. Poor clinical outcomes and immunoevasive contexture in CD161
Chen Q; Yin H; Jiang Z; He T; Xie Y; Mao W; Han J; Liu S; Lou W; Wu W; Habib JR; Yu J; Liu L; Pu N
J Immunother Cancer; 2024 Mar; 12(3):. PubMed ID: 38531664
[TBL] [Abstract][Full Text] [Related]
14. Perineural Invasion Reprograms the Immune Microenvironment through Cholinergic Signaling in Pancreatic Ductal Adenocarcinoma.
Yang MW; Tao LY; Jiang YS; Yang JY; Huo YM; Liu DJ; Li J; Fu XL; He R; Lin C; Liu W; Zhang JF; Hua R; Li Q; Jiang SH; Hu LP; Tian GA; Zhang XX; Niu N; Lu P; Shi J; Xiao GG; Wang LW; Xue J; Zhang ZG; Sun YW
Cancer Res; 2020 May; 80(10):1991-2003. PubMed ID: 32098780
[TBL] [Abstract][Full Text] [Related]
15. An increased abundance of tumor-infiltrating regulatory T cells is correlated with the progression and prognosis of pancreatic ductal adenocarcinoma.
Tang Y; Xu X; Guo S; Zhang C; Tang Y; Tian Y; Ni B; Lu B; Wang H
PLoS One; 2014; 9(3):e91551. PubMed ID: 24637664
[TBL] [Abstract][Full Text] [Related]
16. CD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
Wang R; Chen J; Wang W; Zhao Z; Wang H; Liu S; Li F; Wan Y; Yin J; Wang R; Li Y; Zhang C; Zhang H; Cao Y
J Immunother Cancer; 2022 Jan; 10(1):. PubMed ID: 35086948
[TBL] [Abstract][Full Text] [Related]
17. Single-cell RNA sequencing reveals compartmental remodeling of tumor-infiltrating immune cells induced by anti-CD47 targeting in pancreatic cancer.
Pan Y; Lu F; Fei Q; Yu X; Xiong P; Yu X; Dang Y; Hou Z; Lin W; Lin X; Zhang Z; Pan M; Huang H
J Hematol Oncol; 2019 Nov; 12(1):124. PubMed ID: 31771616
[TBL] [Abstract][Full Text] [Related]
18. Characterization of natural killer and cytotoxic T-cell immune infiltrates in pancreatic ductal adenocarcinoma.
Persky J; Cruz SM; Darrow MA; Judge SJ; Li Y; Bold RJ; Karnezis AN; Matsukuma KE; Qi L; Canter RJ
J Surg Oncol; 2024 Apr; 129(5):885-892. PubMed ID: 38196111
[TBL] [Abstract][Full Text] [Related]
19. [Pathological features related to onco-immunity and their clinical significance of pancreatic ductal adenocarcinoma].
Wang CM; Xu CY; Jiang S; Zhou Q; Jiang ZJ; Cheng GP; Wu MJ; Feng TT; Yin WJ
Zhonghua Bing Li Xue Za Zhi; 2022 May; 51(5):419-424. PubMed ID: 35511637
[No Abstract] [Full Text] [Related]
20. Artificial intelligence-based comprehensive analysis of immune-stemness-tumor budding profile to predict survival of patients with pancreatic adenocarcinoma.
Zhou T; Man Q; Li X; Xie Y; Hou X; Wang H; Yan J; Wei X; Bai W; Liu Z; Liu J; Hao J
Cancer Biol Med; 2023 Mar; 20(3):196-217. PubMed ID: 36971107
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]